top of page
strip900.jpg

Slenyto

®

Sleep more. Rest more.

Achieve more.

what is Slenyto?

Why Slenyto®?

​

Slenyto® is the first and only pharmacotherapy that is approved for the treatment of Neurogenetic Disorders (NGDs).

​

Slenyto® is a prolonged-release melatonin minitablet developed specifically for the treatment of insomnia in these children, addressing their specific needs. 

Slenyto symbol
Slenyto package
Benefits
Taking Slenyto​
​

  • Easy to swallow -Just 3mm diameter

  • Dose adjustable

  • Favourable safety 

pce1.png
Proven Clinical Evidence
​

  • Improves main sleep parameters

  • Improves daytime behavior

  • Improves parents well-being

TM2.png
Easy to Manage
​

  • Doze optimization

  • Treatment evaluation

Insomnia & Autism
girlGND-copy.png

Insomnia in NGDs

​

The prevalence of insomnia is as high as 80% in children with neurodevelopmental disorders, including those with neurogenetic disorders (NGDs) like Smith Magenis Syndrome, Tuberous Sclerosis Complex, Rett syndrome, Angelman syndrome, Williams Syndrome etc.

 

Providing children with a well-designed medication that delivers melatonin steadily throughout the night- mimicking the natural pattern seen in neurotypical children- is a logical and effective approach to addressing this issue.

bottom of page